XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation Expense (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Restricted Stock Unit Activity

A summary of the restricted stock unit activity under the Plans for the three months ended March 31, 2023 was as follows:

 

 

Shares

 

 

Weighted-
Average
Grant Date Fair Value

 

Restricted stock units outstanding as of December 31, 2022

 

 

28,212

 

 

$

4.78

 

Granted

 

 

270,716

 

 

$

2.85

 

Vested

 

 

(7,041

)

 

$

4.78

 

Forfeited

 

 

(31,271

)

 

$

2.85

 

Restricted stock units outstanding as of March 31, 2023

 

 

260,616

 

 

$

3.01

 

 

Summary of Stock Option Activity Under Plans

A summary of the stock option activity under the Plans for the three months ended March 31, 2023 was as follows:

 

 

Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2022

 

 

4,311,333

 

 

$

7.07

 

 

 

8.2

 

 

$

378

 

Granted

 

 

1,424,630

 

 

 

2.75

 

 

 

 

 

 

 

Exercised

 

 

(2,115

)

 

 

2.10

 

 

 

 

 

 

 

Cancelled

 

 

(238,022

)

 

 

7.02

 

 

 

 

 

 

 

Outstanding at March 31, 2023

 

 

5,495,826

 

 

$

5.95

 

 

 

8.5

 

 

$

57

 

Schedule of Fair Value of Stock Option Estimated on Date of Grant Using Black-Scholes Option-Pricing Model in Case of Options Granted to Executive Officers

The fair value of each stock option granted to employees, directors and non-employees was estimated on the date of grant using the Black-Scholes option-pricing model in the case of the options granted to executive officers, with the following weighted-average assumptions for the three months ended March 31:

 

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

Risk-free interest rate

 

 

3.7

%

 

 

2.0

%

Expected dividend yield

 

 

%

 

 

%

Expected term (in years)

 

 

6.0

 

 

 

4.2

 

Expected volatility

 

 

83.3

%

 

 

80.8

%

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense included in the Company’s consolidated statements of operations and comprehensive loss was as follows (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

Research and development

 

$

284

 

 

$

227

 

General and administrative

 

 

1,326

 

 

 

617

 

Total

 

$

1,610

 

 

$

844